olpressor 10 mg õhukese polümeerikattega tablett
sandoz pharmaceuticals d.d. - olmesartaanmedoksomiil - õhukese polümeerikattega tablett - 10mg 56tk; 10mg 280tk; 10mg 7tk; 10mg 60tk; 10mg 30tk; 10mg 14tk; 10mg 100tk; 10mg 500tk
digoxin orifarm 62,5 mcg tablett
orifarm generics a/s - digoksiin - tablett - 62,5mcg 100tk; 62,5mcg 60tk
betoptic s silmatilgad, suspensioon
immedica pharma ab - betaksolool - silmatilgad, suspensioon - 2,5mg 1ml 5ml 1tk
cosmofer süste-/infusioonilahus
pharmacosmos a/s - raud(iii)hüdroksiid-dekstraankompleks - süste-/infusioonilahus - 50mg 1ml 2ml 10tk; 50mg 1ml 2ml 5tk; 50mg 1ml 5ml 10tk
digoxin orifarm 0,25 mg tablett
orifarm healthcare a/s - digoksiin - tablett - 0,25mg 60tk; 0,25mg 50tk
cataflam kaetud tablett
novartis baltics sia - diklofenak - kaetud tablett - 50mg 20tk
voltaren retard toimeainet prolongeeritult vabastav tablett
novartis baltics sia - diklofenak - toimeainet prolongeeritult vabastav tablett - 100mg 10tk; 100mg 30tk
nitrofurantoin orifarm tablett
orifarm healthcare a/s - nitrofurantoiin - tablett - 50mg 20tk
calquence
astrazeneca ab - acalabrutinib - leukeemia, lümfotsüütne, krooniline, b-rakk - antineoplastic agents, protein kinase inhibitors, - calquence as monotherapy or in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll). calquence as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) who have received at least one prior therapy.